Our transcriptomic and epigenomic analysis of CD14+ monocytes indicated that the functional alterations identified in patients with acute severe COVID-19 are accompanied by decreased basal activity of key modules involved in TLR signaling pathways, including NF-κB and AP1. The gene discussed is NFKB1; the disease is COVID-19.